

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine rec...
Q2 2026
Jun 10, 2026
Q1 2026
Mar 9, 2026
FY 2025
Jan 12, 2026
Q4 2025
Jan 12, 2026
Q3 2025
Sep 10, 2025